Antithrombotic Therapy for VTE Disease

ACCP VTE Therapy

ACCP GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/86135

Contents of this Issue

Navigation

Page 6 of 17

VTE Test results ≤ 24 h Low Await test results + Anticoagulation Duration of Anticoagulation to Prevent 2nd 3 months Unprovoked - Distal or proximal Proximal DVT Surgical or transient factor 1st 1st Distal DVT Surgical or transient factor 1st 1st 2nd VTE Low bleed risk Moderate-high bleed risk Cancer Low or moderate bleed risk High bleed risk a For categorization of bleeding risk see Table 2. ✔ ✔ ✔ ✔ ✔ ✔ proximal - Low or moderate bleed risk proximal - High bleed risk proximal - Low or moderate bleed risk proximal - High bleed risk ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ VTEa Extended ✔ ✔ Clinical suspicion Intermediate Test results > 4 h High or confirmed 5

Articles in this issue

Archives of this issue

view archives of Antithrombotic Therapy for VTE Disease - ACCP VTE Therapy